A 2-year-old Pakistani girl with a rare genetic disease that causes mental and motor decline received her baby sister's umbilical blood on Tuesday in the city.
Hansa Biopharma announces positive results from NICE-01 trial of next generation IgG-cleaving molecule, HNSA-5487: Lund, Sweden Tuesday, October 8, 2024, 11:00 Hrs [IST] Hansa Bio ...